Esophageal cancer that metastasizes to bone is rare, but the prognosis is poor. Many studies have been conducted to identify independent risk factors for predicting the development of metastatic esophageal cancer, but the results are ambiguous. Meanwhile, the treatment of esophageal cancer with bone metastases by combining radiation therapy with chemotherapy can only improve the prognosis of patients from 1 to 8 months.